.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Chubb
US Army
Merck
Harvard Business School
Accenture
Novartis
Daiichi Sankyo
Fish and Richardson
Baxter

Generated: December 18, 2017

DrugPatentWatch Database Preview

CELLCEPT Drug Profile

« Back to Dashboard

Which patents cover Cellcept, and when can generic versions of Cellcept launch?

Cellcept is a drug marketed by Roche Palo and is included in four NDAs.

The generic ingredient in CELLCEPT is mycophenolate mofetil hydrochloride. There are thirty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mycophenolate mofetil hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche PaloCELLCEPTmycophenolate mofetilCAPSULE;ORAL050722-001May 3, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetilTABLET;ORAL050723-001Jun 19, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetil hydrochlorideINJECTABLE;INJECTION050758-001Aug 12, 1998APRXYesYes► Subscribe► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetilSUSPENSION;ORAL050759-001Oct 1, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CELLCEPT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche PaloCELLCEPTmycophenolate mofetilSUSPENSION;ORAL050759-001Oct 1, 1998► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetilCAPSULE;ORAL050722-001May 3, 1995► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetilTABLET;ORAL050723-001Jun 19, 1997► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetilSUSPENSION;ORAL050759-001Oct 1, 1998► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetil hydrochlorideINJECTABLE;INJECTION050758-001Aug 12, 1998► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetil hydrochlorideINJECTABLE;INJECTION050758-001Aug 12, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for CELLCEPT

Drugname Dosage Strength RLD Submissiondate
mycophenolic mofetilFor Oral Suspension200 mg/mLCellcept3/25/2011

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKinsey
Covington
Merck
Daiichi Sankyo
Fish and Richardson
Deloitte
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot